Dana Miller Ervin
Dana Miller Ervin is the Holly and Paul Freestone Health Care Reporting fellow, examining the U.S. health care system.
Ervin is an award-winning journalist who has worked at “60 Minutes,” CNBC, “CBS This Morning” and “Nightline.” She has three Emmy Awards for investigative reporting and research, as well as a Peabody Award and an Alfred I. DuPont Award. Ervin has also served as a senior, nonpartisan investigator for the U.S. House Appropriations Committee, digging deep into big government programs.
-
Medicare's decision to limit coverage for a controversial new Alzheimer's drug has prompted an outcry among Alzheimer's advocates. The drug is Aduhelm, and despite widespread enthusiasm for it among Alzheimer's patients and advocates, it hasn't been proven to slow the disease. The drug was given accelerated approval by the Food and Drug Administration because it reduces the plaque that develops in the brains of most Alzheimer’s patients. -
Aduhelm, an expensive Alzheimer's drug, is fomenting controversy — and generating excitement for patients. The FDA approved it last summer. But Adulem’s results are the subject of intense debate — and so is the cost of the drug.
-
Charlotte area hospitals make a profit on patient care, according to an online calculator from the National Academy for State Health Policy.
-
Private equity firms have been buying up and building out autism therapy clinics. Why?
-
North Carolina's $650 million Healthy Opportunities pilot launches Tuesday.
-
North Carolina's Healthy Opportunities Pilot will launch on March 15, allowing some patients to get assistance with food, shelter, transportation and protection from domestic violence.
-
House Bill 96, which passed the state legislature last fall, went into effect Feb. 1. When implemented, it will allow pharmacists to give some medicines without a prescription, including birth control pills.
-
Medic, Mecklenburg County's EMS agency, says staffing shortages and increased demand during the latest COVID-19 surge are straining resources. The agency is making some temporary changes to cope, including increasing wait times for some non-emergency situations.
-
Charlotte's unemployment rate dropped in 2021, and North Carolina's landed some big employers over the course of the year. A Wells Fargo economist says those are all reasons to be bullish about the region's economy heading into 2022.
-
Earlier this month, the U.S. Supreme Court signaled it could overturn Roe. v Wade. And then the FDA made it easier to get abortion pills. Here's how the two could play out in North Carolina.
